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Abstract
Background: Tuberculosis kills five lakh patients every year in 
India, commonest being pulmonary tuberculosis and is often as-
sociated with effusion. Delay in diagnosis and treatment results in 
poor prognosis. Several studies have suggested the role of adenos-
ine deaminase (ADA) in the diagnosis of tuberculous pleural effu-
sions, but false-positive results from lymphocytic effusions have 
also been reported. The purpose of this study is to find out the role 
of ADA levels in differentiation of tuberculous and non-tuberculous 
exudative pleural effusions of different etiologies.
Methods: Ninety-six lymphocytic pleural fluid samples were con-
secutively selected and divided into two groups: tuberculous (n = 
56) and non-tuberculous (n = 40), depending upon the etiology 
[Malignancy (n = 16), Infectious diseases (n = 18), Pulmonary em-
bolism (n = 1), Collagen vascular diseases (n = 3) and Sarcoidosis 
(n = 2)]. ADA was estimated in pleural fluid in all the cases.
Results: In all 56 samples, ADA level of tuberculous group was 
above  diagnostic  cut-off  (40  U/L),  while  only  one  sample  was 
above cut-off in non-tuberculous group (2.5%). The negative pre-
dictive value of ADA for the diagnosis of non-tuberculous etiology 
was 97.5% (39 of 40) lymphocytic pleural effusion patients.
Conclusions: In this study, ADA levels in nontuberculous exuda-
tive pleural effusions rarely exceeded the cut-off; set for tubercu-
lous disease. The pleural fluid ADA levels were significantly higher 
in tuberculous exudative pleural effusions when compared with 
non-tuberculous exudative pleural effusions.
Keywords: Adenosine deaminase; Tuberculous effusion; Pleural 
fluid; Exudative pleural effusions
Introduction
Five lakh patients of tuberculosis die every year in India [1], 
commonest being pulmonary tuberculosis and is often as-
sociated with effusion, of which 8.3 % is childhood tubercu-
losis. Multidrug resistance in tuberculosis and its association 
with acquired immuno-deficiency syndrome (AIDS) has fur-
ther highlighted the importance of this disease. Delay in di-
agnosis and in the start of effective treatment results in poor 
prognosis and sequalae in upto 25% of cases [2]. Available 
methods of diagnosis of tuberculosis were evaluated and all 
of them were found to have low sensitivity and specificity. 
Direct evidence of acid fast bacilli (AFB) is available only in 
small percentage of cases. 
Similar difficulties are encountered in cases of tubercu-
lous pleuritis (TP). TP with effusion as a complication of pri-
mary pulmonary tuberculosis has been reported to occur in 
2 to 38% of children with pulmonary disease, but it is more 
likely to occur in adolescents and adults [3-9]. The pleural 
fluid  of  TP  is  usually  predominantly  lymphocytic.  Some 
studies  suggest  that  pleural  fluid  lymphocyte  percentages 
of more than 85% are very suggestive of tuberculosis [10], 
while the other series of patients with TP indicates that only 
10% patients had less than 50% lymphocytes in pleural fluid 
[11]. Acute TP may show an increase in neutrophils [12]. But 
if a continuous pleural tapping is done, the cell count shows 
change. Apart from tuberculosis the other causes of lym-
phocytic pleural effusions include malignancies, infectious 
diseases, pulmonary embolism, collagen vascular diseases, 
sarcoidosis,  uremia,  chylothorax  and  post-coronary  artery 
bypass graft (CABG) pleural effusion [13]. 
The classification of pleural effusion into exudative and 
transudative to support the clinical diagnosis has been well 
established. There are several causes of exudative pleural 
effusion including tuberculosis, neoplasms (primary or sec-
ondary), pyogenic bacterial infections, fungal infection, sar-
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coidosis, collagen vascular disease, transplant patients with 
graft rejection, trauma, and pulmonary embolism. Micros-
copy of fluid shows neutrophillic predominance in bacte-
rial infectious etiology, while in others there is lymphocytic 
predominance. Presentation of pulmonary embolism can be 
obscure either as a transudative or an exudative pleural col-
lection.
Usefulness of adenosine deaminase (ADA) estimation 
in pleural fluid has been shown as a reliable chemical bio-
marker specially when there is suspicion of tuberculosis in 
endemic areas. Sometimes the increase is marked in early 
stages of the disease and in some other conditions with neu-
trophillic  effusions  like  in  parapneumonic  and  empyema 
[14].  Researchers  have  established  that ADA  level  rarely 
exceeds the cut-off set for tuberculous effusion in non-tuber-
culous lymphocytic effusions [15]. 
The purpose of this study is to find out the role of ADA 
estimation in differentiation of tuberculous and non-tubercu-
lous exudative pleural effusions. 
 
Materials and Methods
The project was approved by institutional ethical committee. 
Patients with pleural effusion admitted in the wards of Tu-
berculosis and chest diseases department from January 08 to 
November 09 at the Subharti Medical College, Meerut, India 
were included in the present study. After the routine proce-
dure of informed consent, history taking and examination, 
routine investigations were done in all the patients. 
Presence of first or more than one of the following crite-
ria was adopted to label a case as tuberculous: (1) bacterio-
logical confirmation of presence of Mycobacterium tuber-
culosis (direct smear or culture or histological finding); (2) 
histopathology finding of caseating granulomas; (3) radio-
logical findings consistent with TB; (4) clinical presentation 
consistent with TB with exclusion of other clinical consid-
erations; (5) definite clinical and radiological improvement 
in two months of administration of exclusive anti-tubercular 
treatment; (6) history of contact of current disease and posi-
tive reaction (> 20 mm induration) to the 5 tuberculin unit 
(TU) purified protein derivative (PPD).
Pleural tap was done in all the cases and fluid tested for 
pH, glucose, proteins, LDH, total ADA, microscopy, cytol-
ogy and microbial testing (Grams staining, Z N Staining, 
cultures). Pleural biopsy was done in selected cases of tuber-
culosis and malignancy. 
All the cases had exudative effusion as per Light’s cri-
teria (pleural fluid protein / serum protein > 0.5; fluid LDH / 
serum LDH > 0.6) [16].
Effusion  was  called  as  malignant  when  pleural  fluid 
cytology or pleural biopsy showed evidence of malignancy 
or if the patient had proved metastatic malignancy with no 
other detectable cause of effusion. In infectious disease effu-
sion, patient had a history of fever and pulmonary infiltrate 
with complete response to antibiotic therapy; pulmonary em-
bolism effusion patients presented with typical dyspnoea of 
sudden onset, leg pains with its signs and symptoms; colla-
gen vascular disease effusion patients had a history of fever 
and dyspnoea with evidence of eosinophilia and arrhythmia 
while sarcoidosis effusion patients had multi organ involve-
ment with presence of non-caseating granuloma.
Adenosine deaminase estimation was done by Blake-
Berman method [17] which is comparable with the Giusti-
Galanti method as is established by a meta-analysis of 2251 
cases [18]. Adenosine deaminase Level of more than 40 U/L 
is taken as cut-off for tuberculosis, same value was taken by 
other workers also [19].
 
Statistical analysis
Results are expressed as Mean ± SD. The statistical analyses 
applied included the standard normal variate test, to analyze 
the difference between tubercular (n = 56) and non-tubercu-
lar (n = 40) quantitative variable’s at 1% level of significance 
(Table 4). 
 
Results
In our study, 96 samples were thus included between the age 
group of 12 to 76 years. Male : Female ratio is 3 : 1. Tuber-
culous group had 56 samples while non-tuberculous group 
had 40 samples. Non-tuberculous group included different 
etiologies, namely, malignancy (n = 16), infectious diseases 
(n = 18), pulmonary embolism (n = 1), collagen vascular dis-
eases (CVD) (n = 3) and sarcoidosis (n = 2) (Table 1). 
Out of 56, only 9 cases (16.07%) were confirmed as hav-
ing tuberculosis by bacteriological confirmation of presence 
of Mycobacterium tuberculosis. 
Table 1. Distribution of the Cases According to Accepted 
Criteria
Group Disease Number 
of Cases
Tuberculosis 
(n = 56)
Tuberculosis 56
Non-Tuberculosis  
(n = 40)
Malignancy 16
Infectious diseases 18
Pulmonary embolism 1
Collagen vascular disease 3
Sarcoidosis 2
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Mean ± SD of pH in tuberculous group was 7.31 ± 0.09, 
in malignant group it was 7.32 ± 0.07,  in infectious disease 
group it was 7.31 ± 0.08, in pulmonary embolism it was 
7.29,  in CVD group it was 7.27 ± 0.05 while in sarcoidosis 
it was 7.32 ± 0.03 (Table 2).   
Mean ± SD of glucose in tuberculous group was 46.2 
± 17.6, in malignant group it was 42.2 ± 19.6,  in infectious 
disease group it was 31.4 ± 17.8, in pulmonary embolism it 
was 40.7,  in CVD group it was 51.5 ± 14.6 while in sarcoid-
osis it was 58.8 ± 18.9 mg % (Table 2).     
Mean ± SD of protein in tuberculous group was 4.3 ± 
0.9, in malignant group it was 4.2 ± 1.1,  in infectious disease 
group it was 4.1 ± 1.2, in pulmonary embolism it was 3.9,  in 
CVD group it was 4.4 ± 0.7 while in sarcoidosis it was 4.2 ± 
0.9 gm % (Table 2).    
Mean ± SD of LDH in tuberculous group was 151.6 ± 
27.0, in malignant group it was 147.4 ± 18.6,  in infectious 
disease group it was 141.7 ± 23.1, in pulmonary embolism 
it was 136.0,  in CVD group it was 154.6 ± 13.7 while in 
sarcoidosis it was 148.6 ± 11.6 U/L (Table 2).     
In tuberculous group the range of ADA was 115.4 (40.6 
- 156.0) and mean ± SD was 67.34 ± 22.85 while collectively 
in non-tuberculous group it was 33.2 (4.8 - 38.0) and 18.60 
± 9.12  (Table 3). 
Amongst different groups in non-tuberculous disease: in 
malignant group range of ADA was 26.6 (6.4 - 33.0) and 
mean ± SD was 9.08 ± 9.96, in infectious disease group its 
range was 27.2 (4.8 - 32.0) and mean ± SD was 18 ± 7.83, in 
pulmonary embolism it was 13.58, in CVD group its range 
was 5 (10.0 - 15.0) and mean ± SD was 12 ± 2.65, in sarcoid-
Table 2. Biochemical Parameters in Pleural Fluid in Different Groups
Table 3. ADA Range With Mean ± SD in Different Groups
Group Disease pH Glucose mg% Protein g% LDH U/L
Tubercular 
(n = 56)
Tuberculosis  
(n = 56)
7.31 ± 0.09 46.2 ± 17.6 4.3 ± 0.9 151.6 ± 27.0
Non-Tubercular   
(n = 40)
Malignant (n = 16) 7.32 ± 0.07 42.2 ± 19.6 4.2 ± 1.1 147.4 ± 18.6
Infectious diseases  
(n = 18)
7.31 ± 0.08 31.4 ± 17.8 4.1 ± 1.2 141.7 ± 23.1
Pulmonary embolism  
(n = 1)
7.29 40.7 3.9 136.0
Collage Vascular Disease  
(n = 3)
7.27 ± 0.05 51.5 ± 14.6 4.4 ± 0.7 154.6 ± 13.7
Sarcoidosis  
(n = 2)
7.32 ± 0.03 58.8 ± 18.9 4.2 ± 0.9 148.6 ± 11.6
Group Disease Range Mean ± SD
Tubercular (n = 56) TB (n = 56) 115.4 (40.6 - 156.0) 67.34 ± 22.85
Non-Tubercular  
(n = 40)
Over all 33.2 (4.8 - 38.0) 18.60 ± 9.12
Malignant (n = 16) 26.6 (6.4 - 33.0) 9.08 ± 9.96
Infectious diseases (n = 18) 27.2 (4.8 - 32.0) 18 ±  7.83
Pulmonary embolism (n = 1) 13.58 --
Collagen Vascular Disease (n = 3) 5 (10.0 - 5.0) 12 ± 2.65
Sarcoidosis (n = 2) 8 (30.0 - 38.0) 34 ± 5.66
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osis group its range was 8 (30.0 - 38.0) and mean ± SD was 
34 ± 5.66 U/L (Table 3).    
Adenosine deaminase level in all 56 samples of tuber-
culous group was above diagnostic cut-off (40 U/L); while 
in non-tuberculous group only one sample was above cut-
off (2.5%). The negative predictive value of ADA for the 
diagnosis of non-tuberculous etiology was 97.5% (39 of 40) 
exudative pleural effusion patients (Table 4).  
Adenosine deaminase values were compared between 
tuberculous and non-tuberculous groups and difference in 
these values was statistically highly significant. On com-
paring  the ADA  values  amongst  different  non-tubercular 
groups; the difference was not statistically significant (Table 
4).  
Discussion
  
Tuberculous pleurisy (TP) is a result of delayed hypersen-
sitivity  reaction  to  the  tubercle  bacilli.  Exudative  pleural 
effusion is manifested by various diseases. The diagnosis 
based on pleural tap: AFB staining is positive in only 10 to 
25% of the cases, while culture for AFB is positive in less 
than 25% of the cases [20]. Perez et al in their study have 
shown the positivity for tubercle bacilli with smear alone in 
pleural fluid is 11.1% [21], with culture it is 33.3% and with 
pleural biopsy it increases up to 96.2%. These values differ 
among different workers [22, 23]. One third of patients with 
this condition can have a negative tuberculin skin test [11]. 
Sensitive techniques like PCR show positive results in about 
50% of cases [24].  
In patients with tuberculous exudative pleural effusion, 
neutrophils predominate in the early stages of the disease, 
while abundant mononuclear cells is a classical finding later 
and is believed to be due to the proliferation and differen-
tiation of lymphocytes which release lymphokines, which 
in turn activate macrophages for an enhanced bactericidal 
activity [25, 26]. Even pleural fluid cytology takes a back 
seat while investigating the cause of an exudative pleural 
effusion, and is usually just evidence supporting our final 
diagnosis.
Since the conventional diagnostic tools are incapable of 
pinpointing the cause, so several bio-markers like ADA, in-
terferon (IFN)-γ, a variety of tumor markers and cytokines, 
and C-reactive protein (CRP) have been proposed as alterna-
tive noninvasive means of establishing tuberculous etiology 
in cases of exudative pleural effusion [27]. 
Adenosine  deaminase  estimation  in  pleural  fluid  has 
long been taken as a marker for tuberculous pleurisy. Levels 
above 40 U/L indicate pleural tuberculosis with sensitivity 
81 to 100% and specificity 83 to 100% [28-30], while some 
other workers have observed that this cut-off indicates a still 
higher sensitivity of 90 - 100% and specificity of 89 - 100% 
[29, 31-35]. False positive cases reported could be due to 
empyema, lymphoma, malignancy, parapneumonic or colla-
gen vascular disease [29, 36]. 
The ADA is an enzyme involved in the purine catabo-
lism. It catalyzes the deamination of adenosine to inosine and 
of deoxyadenosine to deoxyinosine. Adenosine deaminase is 
involved in the proliferation and differentiation of lympho-
cytes,  specifically  the  T-lymphocytes.  The  T-cells  release 
ADA during the process of activation in the presence of live 
intracellular pathogens. Thus ADA has been looked upon as 
a marker of cell mediated immune response and specifically 
T-cell activation. There are several known isoforms of ADA, 
which arise from different gene loci [37] out of which ADA-
1 is found in all cells including lymphocytes and monocytes, 
while ADA-2 is found exclusively in monocytes [38]. ADA-
2 isoform is the one raised in tuberculous pleurisy, account-
ing for almost 88% of total ADA activity. Rise in ADA-1 
activity is more commonly associated with pyogenic bacte-
rial infection of the pleural cavity, contributing to a median 
70% of total ADA activity [34]. However there is no clear 
advantage of using the ADA-2 over the total ADA activity in 
clinical practice [25]. The total ADA activity assay is in fact 
preferred for its rapid turnover and low cost.
Table 4. Pleural Fluid ADA Levels With Their Significance
*p < 0.01 shows a highly significant difference between the tuberculous and non-tuberculous groups.
Group Number of 
Cases
ADA Levels 
in U/L
True Positive / 
Negative Cases
Mean  + SD z cal P-value
Tuberculous 56 > 40
≤ 40
56
00
67.34  +  22.85
14.48 0.0007 (p <0.01)*
Non-tuberculous 40 > 40
≤ 40
01
39
18.60  +  9.12
Total 96 96
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Daniil et al, in their study, concluded that the combi-
nation of pleural ADA and CRP levels might be sufficient 
for discriminating between the different groups of exudative 
pleural  effusion  [27].  Jadhav  and  Bardapurkar  concluded 
that ADA is a useful biochemical marker to evaluate exuda-
tive pleural effusions [39]. 
We have found the pleural fluid ADA levels to be con-
sistently  increased  and  more  than  the  cut-off  (40U/L)  in 
cases of exudative pleural effusions of tuberculous etiology. 
In cases with non-tubercular exudative pleural effusion the 
ADA levels were found to be consistently below the cut-off. 
The negative predictive value of ADA for the diagnosis of 
non-tuberculous etiology was 97.5%. Therefore, pleural flu-
id ADA levels can play a very significant role in differentiat-
ing cases of exudative pleural effusion into tuberculous and 
non-tuberculous.
On the contrary, Rafael concluded that the ADA assay 
should be considered as a screening test to guide further di-
agnostic procedures in cases of exudative pleural effusion 
[40]. While Kataria and Imtiaz concluded that ADA testing 
can be an integral part of diagnostic workup in lymphocyte 
rich exudative body fluids both in countries with high and 
low prevalence of tuberculosis [25].
The sensitivity of the ADA as a serological marker for 
tuberculous exudative pleural effusion depends on the preva-
lence of the disease in the population. In western countries 
where the prevalence of tuberculosis is low, the positive pre-
dictive value of the test decreases because of the high false 
positives, but the negative predictive value remains high. 
Thus ADA can be used for ruling out suspected cases of tu-
berculosis and can be a very effective screening test.
India has a high prevalence of tuberculosis and the sen-
sitivity and specificity of this test will be high in this popu-
lation. Therefore ADA estimation being a simple, low cost, 
rapid and non-invasive test, should become an integral part 
of the diagnostic work up of exudative pleural effusions in 
suspected cases of tuberculosis.
In conclusion, in this study, ADA levels in non-tuber-
culous exudative pleural effusions rarely exceeded the cut-
off; set for tuberculous disease. The pleural fluid ADA levels 
were significantly higher in tuberculous exudative pleural 
effusions when compared with non-tuberculous exudative 
pleural effusions. Adenosine deaminase level of less than 40 
U/L practically excludes the tubercular etiology in exudative 
pleural effusion cases and thus may be useful in differenti-
ating tuberculous etiology from others in exudative pleural 
effusion. 
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